911½ñÈÕºÚÁÏ

Professor Pizzo specialises in health economics alongside clinical trials, with expertise in economic evaluation, health technology assessment and decision modelling. Her work supports evidence-based decision making across digital health, cancer, diagnostics, mental health and public health.

Professor Cornelius is a leading expert in medical statistics and innovative clinical trial designs. Her research focuses on adaptive methodologies, the evaluation of complex interventions and improving the analysis of safety outcomes to make trials more efficient and informative.

Dr Cro specialises in the design and analysis of clinical trials across diverse health conditions. Her methodological research focuses on estimands, missing data, sensitivity analyses and adaptive trial designs to strengthen the quality and interpretation of trial evidence.

Dr Lemanska leads ICTU's Digital Health Trial Portfolio, advancing the evaluation of digital interventions through innovative trial design. Her expertise includes real-world evidence, NHS data, trial emulation and quasi-experimental approaches.

Dr Phillips leads statistical innovation in clinical trials, with expertise in adaptive designs, adverse event analysis and trial methodology. Her work develops robust statistical approaches that improve the safety, efficiency and reliability of clinical trials research.

Professor Costelloe leads research at the intersection of health informatics, data science and real-world evidence. She develops and evaluates data-driven healthcare interventions using electronic patient records and advanced causal inference methods to strengthen clinical research.

Professor Gale is an expert in neonatal and paediatric clinical trials, with a focus on pragmatic trial design and the use of routinely collected healthcare data. His research advances innovative approaches to evidence generation in newborn and child health.

An internationally recognised leader in preventive cardiovascular medicine and global clinical trials, Professor Poulter has led landmark studies in hypertension, diabetes and cardiovascular disease. His expertise spans trial leadership, epidemiology and the development of evidence that shapes international clinical practice.

Professor Ray is an internationally recognised preventive cardiologist who leads major global trials, registries and academic industry research programmes. His expertise spans cardiovascular prevention, lipid disorders, diabetes, biomarkers and translating research into policy and clinical practice.